Tonix Long Term Investments vs Property Plant Equipment Analysis
TNXP Stock | USD 0.11 0.04 26.67% |
Tonix Pharmaceuticals financial indicator trend analysis is much more than just breaking down Tonix Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Tonix Pharmaceuticals is a good investment. Please check the relationship between Tonix Pharmaceuticals Long Term Investments and its Property Plant Equipment accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tonix Pharmaceuticals Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Long Term Investments vs Property Plant Equipment
Long Term Investments vs Property Plant Equipment Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Tonix Pharmaceuticals Long Term Investments account and Property Plant Equipment. At this time, the significance of the direction appears to have pay attention.
The correlation between Tonix Pharmaceuticals' Long Term Investments and Property Plant Equipment is -0.76. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of Tonix Pharmaceuticals Holding, assuming nothing else is changed. The correlation between historical values of Tonix Pharmaceuticals' Long Term Investments and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Tonix Pharmaceuticals Holding are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Long Term Investments i.e., Tonix Pharmaceuticals' Long Term Investments and Property Plant Equipment go up and down completely randomly.
Correlation Coefficient | -0.76 |
Relationship Direction | Negative |
Relationship Strength | Weak |
Long Term Investments
Long Term Investments is an item on the asset side of Tonix Pharmaceuticals balance sheet that represents investments Tonix Pharmaceuticals intends to hold for over a year. Tonix Pharmaceuticals Holding long term investments may include different instruments such as stocks, bonds, real estate and cash.Property Plant Equipment
Most indicators from Tonix Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Tonix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Tonix Pharmaceuticals Holding. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. At this time, Tonix Pharmaceuticals' Selling General Administrative is relatively stable compared to the past year. As of 06/06/2024, Enterprise Value Over EBITDA is likely to grow to 0.08, while Enterprise Value is likely to drop (8.7 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 92.3M | 112.1M | 117.1M | 123.0M | Cost Of Revenue | 92.3M | 112.1M | 9.0M | 8.6M |
Tonix Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Tonix Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Tonix Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 14.6M | 98.2M | 240.9M | 225.7M | 154.5M | 162.2M | |
Other Current Liab | 1.0M | 2.5M | 5.1M | 6.4M | 9.5M | 10.0M | |
Total Current Liabilities | 5.1M | 9.8M | 21.7M | 18.2M | 18.9M | 19.8M | |
Total Stockholder Equity | 9.4M | 87.6M | 218.7M | 207.2M | 105.5M | 53.9M | |
Net Debt | (10.9M) | (75.8M) | (177.7M) | (119.5M) | (15.1M) | (15.9M) | |
Retained Earnings | (217.1M) | (267.5M) | (359.8M) | (470.0M) | (600.7M) | (570.6M) | |
Cash | 11.2M | 77.1M | 178.7M | 120.2M | 24.9M | 37.7M | |
Cash And Short Term Investments | 11.2M | 77.1M | 178.7M | 120.2M | 24.9M | 39.9M | |
Net Receivables | 1.0M | 7.6M | 7.7M | 8.0M | 4.6M | 3.7M | |
Common Stock Total Equity | 3K | 9K | 206K | 496K | 570.4K | 598.9K | |
Common Stock Shares Outstanding | 8.0K | 473.0K | 1.8M | 5.7M | 17.0M | 17.9M | |
Liabilities And Stockholders Equity | 14.6M | 98.2M | 240.9M | 225.7M | 154.5M | 162.2M | |
Other Stockholder Equity | 226.5M | 355.0M | 578.1M | 677.3M | 706.4M | 741.7M | |
Total Liab | 5.1M | 10.5M | 22.2M | 18.5M | 48.9M | 51.4M | |
Total Current Assets | 13.9M | 88.0M | 189.0M | 130.8M | 47.8M | 44.4M | |
Common Stock | 9K | 206K | 496K | 76K | 59.0K | 67.6K | |
Accounts Payable | 3.1M | 4.6M | 13.3M | 8.1M | 3.8M | 3.2M | |
Net Tangible Assets | 9.3M | 87.5M | 218.7M | 207.2M | 238.3M | 250.2M | |
Property Plant And Equipment Net | 390K | 9.8M | 51.5M | 94.5M | 94.9M | 99.6M | |
Current Deferred Revenue | 704K | 2.2M | 2.8M | 3.3M | 3.0M | 1.7M | |
Non Current Assets Total | 610K | 10.2M | 51.9M | 94.9M | 106.7M | 112.0M | |
Retained Earnings Total Equity | (188.5M) | (217.1M) | (267.5M) | (359.8M) | (323.8M) | (307.6M) | |
Non Current Liabilities Total | 6K | 716K | 467K | 328K | 30.0M | 31.6M | |
Capital Surpluse | 212.2M | 226.5M | 355.0M | 578.1M | 664.9M | 698.1M | |
Other Current Assets | 2.7M | 10.9M | 10.4M | 10.5M | 4.1M | 3.6M | |
Property Plant And Equipment Gross | 390K | 9.8M | 51.9M | 96.2M | 100.2M | 105.2M | |
Accumulated Other Comprehensive Income | (46K) | (62K) | (92K) | (167K) | (232K) | (220.4K) | |
Property Plant Equipment | 34K | 9.8M | 51.5M | 94.5M | 108.7M | 114.1M | |
Net Invested Capital | 9.4M | 87.6M | 218.7M | 207.2M | 112.1M | 107.4M | |
Net Working Capital | 8.8M | 78.2M | 167.3M | 112.6M | 28.9M | 27.4M | |
Capital Stock | 9K | 206K | 496K | 76K | 59K | 56.1K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectAdditional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.